| Literature DB >> 28789628 |
Gerrit Bode1, Thorsten Hammer2, N Karvouniaris3, M J Feucht3, L Konstantinidis3, N P Südkamp3, A Hirschmüller3,4.
Abstract
BACKGROUND: The prevalence of patellar tendinopathy is elevated in elite soccer compared to less explosive sports. While the burden of training hours and load is comparably high in youth elite players (age < 23 years), little is known about the prevalence of patellar tendinopathy at this age. There is only little data available on the influence of age, the amount of training, the position on the field, as well as muscular strength, range of motion, or sonographical findings in this age group. The purpose of the present study was to examine the above-mentioned parameters in all age groups of a German youth elite soccer academy.Entities:
Keywords: Jumper’s knee; Patellar tendinopathy; Soccer; Youth elite players
Mesh:
Year: 2017 PMID: 28789628 PMCID: PMC5549401 DOI: 10.1186/s12891-017-1690-2
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Distribution of players sustaining acute PTS according to the different age groups showing that the U-17 team sustains the highest risk of PTS onset (Odds ratio 1.89)
Baseline descriptive statistics of players’ characteristics
| Min | Max | Mean | Std | |
|---|---|---|---|---|
| Age (years) | 10.00 | 23.00 | 15.94 | 2.24 |
| Height (cm) | 138 | 193.00 | 174.64 | 10.17 |
| Weight (kg) | 30 | 100.00 | 65.56 | 13.5 |
| BMI | 14.54 | 26.85 | 21.23 | 2.65 |
| Training units/week | 3 | 10.00 | 5.43 | 1.88 |
| Training h/week | 4.5 | 20.00 | 10.35 | 3.86 |
Soccer specific values and jumper’s knee prevalence
| Number | Percent | |
|---|---|---|
| U-17 | 56 | 47.5 |
| U-19 | 27 | 22.90 |
| U-23 | 16 | 13.60 |
| Total | 119 | |
| Shoes with cleats | 94 | 79.70 |
| Shoes without cleats | 5 | 3.40 |
| Both | 15 | 4.20 |
| Goalkeeper | 15 | 12.70 |
| Central Defender | 17 | 14.40 |
| Lateral Defender | 15 | 12.70 |
| Midfield | 18 | 15.30 |
| Offense | 43 | 36.40 |
| Inlays in Soccer shoes | 5 | 4.20 |
| Inlays in all shoes | 13 | 11.00 |
| No inlays | 92 | 78.00 |
| Left leg dominance | 72 | 61.00 |
| Right leg dominance | 39 | 33.10 |
| Acute Patellar tendinopathy | 13 | 13.60 |
| History of patellar tendinopathy | 32 | 27.10 |
Results of ultrasound examination demonstrating high prevalence of structural changes
|
| Percent | |
|---|---|---|
| Tendon thickening | 9 | 7.60 |
| Hypo echogenicity | 43 | 36.40 |
| Hyper echogenicity | 17 | 14.40 |
| No Neovascularization | 38 | 32.20 |
| Neovascularization I° | 33 | 28.00 |
| Neovascularization II° | 22 | 18.60 |
| Neovascularization III° | 16 | 13.60 |
| Neovascularization IV° | 4 | 3.40 |
| Tendon thickness origin (mm) | 5.43 ± 0.92 | |
| Tendon thickness thickest part (mm) | 2.65 ± 0.65 |
Fig. 2Measurement of patellar tendon thickness at the thickest aspect of the tendon with significant thickening in tendons with acute PTS
Fig. 3Sonographical findings in a player of the U-17 team with acute PTS in the right knee. Structural changes like hypo-echogenic areas; neovascularization and tendon thickening were all detectable
Comparison of VISA-P values in total and specific subscales divided by acute PTS syndrome, demonstrating significant lower scores for players sustainig acute PTS
| No- PTS | PTS |
| |
|---|---|---|---|
| Visa P1 | 9.92 ± 0.37 | 7.73 ± 2.63 | 0.00 |
| VISA P2 | 9.92 ± 0.29 | 9.13 ± 1.13 | 0.00 |
| VISA P3 | 9.88 ± 0.73 | 8.86 ± 2.01 | 0.00 |
| VISA P4 | 9.77 ± 0.85 | 6.87 ± 3.11 | 0.00 |
| VISA P5 | 9.50 ± 1.38 | 6.06 ± 2.42 | 0.00 |
| VISA P6 | 9.76 ± 0.75 | 7.8 ± 2.43 | 0.00 |
| VISA P7 | 9.99 ± 0.10 | 8.8 ± 2.21 | 0.00 |
| VISA P8 | 30.00 ± 0.00 | 21.53 ± 9.61 | 0.00 |
| VISA total | 98.77 ± 2.88 | 76.80 ± 18.65 | 0.00 |